Inventor · disambiguated record
Allan Kirk
Also filed as: KIRK ALLAN · KIRK ALLAN D
4 granted patents·9 pending applications·1 citations·filing 2002–2024
60Inventor score
Top patents by PatentIndex Score
13 records- 0175US10488413B2Methods for treating patients at risk for costimulation blockade resistant rejection with belataceptBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Nov 26, 2019·1 cites·6 claims
- 0271US2022334112A1Methods for treating costimulation blockade resistant rejectionBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 0367US11385228B2Methods for treating costimulation blockade resistant rejectionBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 12, 2022·0 cites·4 claims
- 0463US2024368298A1Gene signatures for monitoring acute rejection and methods of using sameUNIV DUKE·Filed 2024·Application pending·0 cites
- 0558US2007244053A1Use of a CD40:CD154 binding interruptor to prevent counter-adaptive immune responses, particularly graft rejectionKIRK ALLAN D·Filed 2006·Application pending·0 cites
- 0657US2016153990A1Methods for identifying patients at risk for costimulation blockade resistant rejectionBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 0756US12084509B2Gene signatures for monitoring acute rejection and methods of using sameUNIV DUKE·Filed 2021·Granted Sep 10, 2024·0 cites·14 claims
- 0853US2007212701A1Methods for diagnosing and treating ischemia and reperfusion injury and compositions thereofO'TOOLE MARGOT M·Filed 2006·Application pending·0 cites
- 0950US2002119150A1Use of a CD40:CD154 binding interruptor to prevent counter-adaptive immune responses, particularly graft rejectionUS NAVY·Filed 2002·Application pending·0 cites
- 1047US2003161827A1Therapies that improve graft survivalFiled 2002·Application pending·0 cites
- 1140US8546095B2Methods for determination of calcineurin activity and uses in predicting therapeutic outcomesTUMLIN JAMES·Filed 2010·Granted Oct 1, 2013·0 cites·11 claims
- 1237US2006171944A1N-formyl peptide receptor mediation of platelet chemotaxis toward injured cells and activation of immune responseLEKSTROM-HIMES JULIE A·Filed 2002·Application pending·0 cites
- 1336US2008124343A1Treatment of Inappropriate Immune ResponsesXU HE·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Allan Kirk files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →